Dishman Pharma on outlook for 2013
J R Vyas, MD of Dishman Pharma, speaks to NDTV Profit about the outlook for 2013. The company is planning to bring down debt by Rs 120 cr by selling land. It is also counting on its Bawla facility to aid growth in 2013, Mr Vyas says.
